Weiyang He

1.4k total citations
40 papers, 1.0k citations indexed

About

Weiyang He is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Weiyang He has authored 40 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 16 papers in Surgery and 12 papers in Cancer Research. Recurrent topics in Weiyang He's work include MicroRNA in disease regulation (7 papers), Extracellular vesicles in disease (7 papers) and Bladder and Urothelial Cancer Treatments (7 papers). Weiyang He is often cited by papers focused on MicroRNA in disease regulation (7 papers), Extracellular vesicles in disease (7 papers) and Bladder and Urothelial Cancer Treatments (7 papers). Weiyang He collaborates with scholars based in China, United States and United Kingdom. Weiyang He's co-authors include Xin Gou, Hubin Yin, Gongmin Zhu, Lin Fan, Xinyuan Li, Qifa Ye, Yanfeng Wang, Nian Liu, Lijiao Pei and Xin Gou and has published in prestigious journals such as SHILAP Revista de lepidopterología, The FASEB Journal and International Journal of Molecular Sciences.

In The Last Decade

Weiyang He

39 papers receiving 1.0k citations

Peers

Weiyang He
Shenming Wang China
Jun Shi China
Weijie Du China
Ai Peng China
Mingwei Chen China
Yang Dong China
Tongyu Zhu China
Yuanjun Jiang China
Pingsheng Chen China
Shenming Wang China
Weiyang He
Citations per year, relative to Weiyang He Weiyang He (= 1×) peers Shenming Wang

Countries citing papers authored by Weiyang He

Since Specialization
Citations

This map shows the geographic impact of Weiyang He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiyang He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiyang He more than expected).

Fields of papers citing papers by Weiyang He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiyang He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiyang He. The network helps show where Weiyang He may publish in the future.

Co-authorship network of co-authors of Weiyang He

This figure shows the co-authorship network connecting the top 25 collaborators of Weiyang He. A scholar is included among the top collaborators of Weiyang He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiyang He. Weiyang He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Xiang, Li Mao, Haitao Yu, et al.. (2024). Roles of Akirin1 in early prediction and treatment of graft kidney ischemia‒reperfusion injury. SHILAP Revista de lepidopterología. 3(2). e20230043–e20230043. 4 indexed citations
2.
Yu, Haitao, Chunlin Zhang, Xuesong Bai, et al.. (2024). Identifying endoplasmic reticulum stress-related genes as new diagnostic and prognostic biomarkers in clear cell renal cell carcinoma. Translational Andrology and Urology. 13(1). 1–24. 2 indexed citations
3.
Li, Xinyuan, Xiang Zhou, Li Mao, et al.. (2023). Small extracellular vesicles delivering lncRNA WAC-AS1 aggravate renal allograft ischemia‒reperfusion injury by inducing ferroptosis propagation. Cell Death and Differentiation. 30(9). 2167–2186. 33 indexed citations
4.
Zhang, Meng, et al.. (2023). Development and validation of cancer-associated fibroblasts-related gene landscape in prognosis and immune microenvironment of bladder cancer. Frontiers in Oncology. 13. 1174252–1174252. 4 indexed citations
5.
Zhu, Junlong, et al.. (2023). YTHDF1 Promotes Bladder Cancer Cell Proliferation via the METTL3/YTHDF1–RPN2–PI3K/AKT/mTOR Axis. International Journal of Molecular Sciences. 24(8). 6905–6905. 21 indexed citations
6.
Yin, Hubin, Chen Zhang, Zongjie Wei, et al.. (2022). EGF-induced nuclear translocation of SHCBP1 promotes bladder cancer progression through inhibiting RACGAP1-mediated RAC1 inactivation. Cell Death and Disease. 13(1). 39–39. 17 indexed citations
7.
8.
Ye, Shaojun, Dongjing Liu, Weiyang He, et al.. (2021). Assessment of Donor Liver Pathology Predicts Survival After Liver Transplantation: A Retrospective Cohort Study. Transplantation Proceedings. 53(10). 2963–2970. 2 indexed citations
9.
Xie, Yongpeng, Luyao Chen, Yu Gao, et al.. (2020). miR-363 suppresses the proliferation, migration and invasion of clear cell renal cell carcinoma by downregulating S1PR1. Cancer Cell International. 20(1). 227–227. 13 indexed citations
10.
Zhu, Xin, Hang Tong, Hubin Yin, et al.. (2020). C1QTNF6 Overexpression Acts as a Predictor of Poor Prognosis in Bladder Cancer Patients. BioMed Research International. 2020(1). 7139721–7139721. 6 indexed citations
11.
Zhu, Gongmin, Lijiao Pei, Lin Fan, et al.. (2019). Exosomes from human‐bone‐marrow‐derived mesenchymal stem cells protect against renal ischemia/reperfusion injury via transferring miR‐199a‐3p. Journal of Cellular Physiology. 234(12). 23736–23749. 126 indexed citations
12.
Fan, Lin, et al.. (2019). Bladder cancer cell‑secreted exosomal miR‑21 activates the PI3K/AKT pathway in macrophages to promote cancer progression. International Journal of Oncology. 56(1). 151–164. 107 indexed citations
13.
Fan, Xiaoli, Weiyang He, Xinjiang Zhang, et al.. (2018). SIRT3 a Major Player in Attenuation of Hepatic Ischemia‐Reperfusion Injury by Reducing ROS via Its Downstream Mediators: SOD2, CYP‐D, and HIF‐1α. Oxidative Medicine and Cellular Longevity. 2018(1). 2976957–2976957. 70 indexed citations
14.
Yin, Hubin, Weiyang He, Yunhai Li, et al.. (2018). Loss of DUSP2 predicts a poor prognosis in patients with bladder cancer. Human Pathology. 85. 152–161. 17 indexed citations
15.
16.
17.
He, Weiyang, et al.. (2013). Celastrol protects kidney against ischemia–reperfusion-induced injury in rats. Journal of Surgical Research. 186(1). 398–407. 43 indexed citations
18.
Gou, Xin, et al.. (2012). Laparoscopic radical cystectomy for bladder cancer with prostatic and neurovascular sparing: initial experience. International Urology and Nephrology. 44(3). 787–792. 1 indexed citations
19.
Gou, Xin, et al.. (2011). Gene Silence-Induced Downregulation of Survivin Inhibits Bladder Cancer Cells. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 19(12). 535–541. 4 indexed citations
20.
He, Weiyang, Minjian Kong, Yun Li, et al.. (1998). [A new method for study of the effect of drugs on cancer cells--31PNMR with perfused cell system].. PubMed. 33(2). 117–20. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shenming Wang Breakdown of academic impact, for papers by Jun Shi Breakdown of academic impact, for papers by Weijie Du Breakdown of academic impact, for papers by Ai Peng Breakdown of academic impact, for papers by Mingwei Chen Breakdown of academic impact, for papers by Yang Dong Breakdown of academic impact, for papers by Tongyu Zhu Breakdown of academic impact, for papers by Yuanjun Jiang Breakdown of academic impact, for papers by Pingsheng Chen
Rankless by CCL
2026